Bioventus (BVS) Free Cash Flow (QoQ) (2020 - 2026)
Bioventus (BVS) Free Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn |
| 10 | Bioventus | 967.14 Mn | 937.68 Mn | 105.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 126.23% |
| Mar 28, 2026 | -77.53% |
| Dec 31, 2025 | 32.06% |
| Sep 27, 2025 | 6.56% |
| Jun 28, 2025 | 231.81% |
| Mar 29, 2025 | -209.38% |
| Dec 31, 2024 | 77.07% |
| Sep 28, 2024 | -31.74% |
| Jun 29, 2024 | 342.19% |
| Mar 30, 2024 | -160.73% |
| Dec 31, 2023 | 195.81% |
| Sep 30, 2023 | -180.82% |
| Jul 1, 2023 | 1,118.11% |
| Apr 1, 2023 | -89.64% |
| Dec 31, 2022 | 811.27% |
| Oct 1, 2022 | 24.51% |
| Jul 2, 2022 | 90.64% |
| Apr 2, 2022 | -606.48% |
| Dec 31, 2021 | -37.97% |
| Oct 2, 2021 | -60.01% |